RIPK pathway, as a potential target, for cancer treatment - a review
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.
المؤلف الرئيسي: | |
---|---|
مؤلفون آخرون: | |
التنسيق: | أطروحة |
اللغة: | English |
منشور في: |
Brac University
2024
|
الموضوعات: | |
الوصول للمادة أونلاين: | http://hdl.handle.net/10361/22051 |
id |
10361-22051 |
---|---|
record_format |
dspace |
spelling |
10361-220512024-01-02T21:02:39Z RIPK pathway, as a potential target, for cancer treatment - a review Jahan, Nusrat Chowdhury, Namara Mariam School of Pharmacy, Brac University Cancer RIPK Pathway Inhibitors Therapy Anti-cancer drugs Cancer--Treatment This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023. Cataloged from PDF version of thesis. Includes bibliographical references (pages 45-48). Cancer is one of the most feared diseases whose prevalence has been drastically increasing in recent years. Among different types of treatment options, the development of kinase-targeted cancer therapies is currently the most studied target for potential anti-cancer therapies. After G-protein-coupled receptors, protein kinases significantly grab the attraction as a target of developing anti-cancer drugs. Based on current research, this review article outlines receptor-interacting protein kinases specially RIP1 and RIP3 as attractive targets over other kinases in the treatment of numerous types of cancer, especially for their tumorigenesis functions in cancer metastasis. Nusrat Jahan B. Pharmacy 2024-01-02T10:27:12Z 2024-01-02T10:27:12Z 2023 2023-02 Thesis ID 19146057 http://hdl.handle.net/10361/22051 en Brac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. 48 pages application/pdf Brac University |
institution |
Brac University |
collection |
Institutional Repository |
language |
English |
topic |
Cancer RIPK Pathway Inhibitors Therapy Anti-cancer drugs Cancer--Treatment |
spellingShingle |
Cancer RIPK Pathway Inhibitors Therapy Anti-cancer drugs Cancer--Treatment Jahan, Nusrat RIPK pathway, as a potential target, for cancer treatment - a review |
description |
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023. |
author2 |
Chowdhury, Namara Mariam |
author_facet |
Chowdhury, Namara Mariam Jahan, Nusrat |
format |
Thesis |
author |
Jahan, Nusrat |
author_sort |
Jahan, Nusrat |
title |
RIPK pathway, as a potential target, for cancer treatment - a review |
title_short |
RIPK pathway, as a potential target, for cancer treatment - a review |
title_full |
RIPK pathway, as a potential target, for cancer treatment - a review |
title_fullStr |
RIPK pathway, as a potential target, for cancer treatment - a review |
title_full_unstemmed |
RIPK pathway, as a potential target, for cancer treatment - a review |
title_sort |
ripk pathway, as a potential target, for cancer treatment - a review |
publisher |
Brac University |
publishDate |
2024 |
url |
http://hdl.handle.net/10361/22051 |
work_keys_str_mv |
AT jahannusrat ripkpathwayasapotentialtargetforcancertreatmentareview |
_version_ |
1814307295772803072 |